
|Articles|October 22, 2012
VIDEO: Robert Frantz, MD, Talks About Bloodstream Infection Rates
Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, discusses the rate of bloodstream infections in patients with pulmonary arterial hypertension treated with Veletri. Dr Franz also talks about the PROSPECT registry analysis.
Advertisement
Robert Frantz,
MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic,
discusses the rate of bloodstream infections in patients with pulmonary arterial hypertension treated with Veletri. Dr Franz also talks about the PROSPECT registry analysis.
This video was taken on Sunday, October 21 at the CHEST 2012 conference in Atlanta, GA.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
MFN Drug Agreements Could Raise Prices Worldwide
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
5




